Teleflex resolves FDA concerns at Arrow subsidiary

Wed Jun 22, 2011 4:30 am   

<p>In its October 2007 warning letter, the FDA raised concerns about quality systems control measures, which occurred prior to Teleflex's $2 billion acquisition of Arrow, based in Reading, Pa., that same year .</p>

Read more...